MenACWY-CRM conjugate vaccine, adjuvanted

BIOLOGICAL2 trials

Sponsors

Novartis Vaccines

Conditions

Meningococcal MeningitisPrevention of Meningococcal Disease

Phase 2

Study of the Safety and Immune Response of a Meningococcal Conjugate Vaccine Administered to Healthy Adolescents

CompletedNCT00262041

Novartis VaccinesPrevention of Meningococcal Disease

Start: 2004-10-31End: 2006-03-31Updated: 2018-06-28

Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Children Aged 12-59 Months.

CompletedNCT00310817

Novartis VaccinesMeningococcal Meningitis

Start: 2005-03-31End: 2006-05-31Updated: 2015-11-06